ResMed Inc
Ownership
Ownership Structure
Who owns ResMed Inc (RMD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.4% of the shares are freely tradable; institutional investors hold 70.0%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.76 | 12,317,194 | +1.8 | 06/30/2026 |
| Vanguard Capital Management, LLC | 6.74 | 9,474,129 | +0.1 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 5.63 | 7,913,661 | +0.6 | 06/30/2026 |
| State Street Corp | 4.75 | 6,680,735 | +0.6 | 06/30/2026 |
| Geode Capital Management, LLC | 3.09 | 4,352,320 | +0.0 | 06/30/2026 |
| Bank of New York Mellon Corp | 2.98 | 4,197,610 | -14.8 | 06/30/2026 |
| First Trust Advisors L.P. | 1.62 | 2,278,696 | +48.2 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 3.26 | 4,579,499 | -0.7 | 09/30/2026 |
| Vanguard 500 Index Investor | 2.69 | 3,789,102 | -1.7 | 09/30/2026 |
| Vanguard MStar Mid Cap Index Instl | 2.20 | 3,088,917 | -1.6 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Farrell Michael J. | Chairman and CEO | 479,803 | 111,746,119 $ | Oct 7, 2026 | direct |
| Farrell Peter C | Director | 51,803 | 12,064,919 $ | Sep 2, 2026 | direct |
| Leong Justin | Chief Product Officer | 35,489 | 8,265,388 $ | Aug 14, 2026 | direct |
| Rider Michael J | Global General Counsel | 12,318 | 2,868,862 $ | Oct 23, 2026 | direct |
| Bloomer Aaron | Chief Financial Officer | 9,072 | 2,112,869 $ | Aug 14, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 23, 2026 | Rider Michael J | Global General Counsel | Sell | 400 | 255.00 | 102,000 |
| Oct 7, 2026 | Farrell Michael J. | Chairman and CEO | Sell | 4,991 | 226.33 | 1,129,637 |
| Oct 7, 2026 | Farrell Michael J. | Chairman and CEO | Other | 4,991 | 146.34 | 730,383 |
| Sep 8, 2026 | Farrell Michael J. | Chairman and CEO | Sell | 4,991 | 222.44 | 1,110,191 |
| Sep 8, 2026 | Farrell Michael J. | Chairman and CEO | Other | 4,991 | 146.34 | 730,383 |
| Sep 2, 2026 | Farrell Peter C | Director | Sell | 970 | 234.73 | 227,688 |
| Aug 14, 2026 | Leong Justin | Chief Product Officer | Other | 6,461 | 0.00 | – |
| Aug 14, 2026 | Rider Michael J | Global General Counsel | Other | 3,230 | 0.00 | – |
| Aug 14, 2026 | Farrell Michael J. | Chairman and CEO | Other | 13,547 | 0.00 | – |
| Aug 14, 2026 | Bloomer Aaron | Chief Financial Officer | Other | 9,072 | 0.00 | – |
| Aug 7, 2026 | Farrell Michael J. | Chairman and CEO | Sell | 4,991 | 205.69 | 1,026,596 |
| Aug 7, 2026 | Farrell Michael J. | Chairman and CEO | Other | 4,991 | 146.34 | 730,383 |
| Aug 5, 2026 | Farrell Peter C | Director | Sell | 8,000 | 225.00 | 1,800,000 |
| Jul 7, 2026 | Farrell Michael J. | Chairman and CEO | Sell | 4,991 | 218.55 | 1,090,771 |
| Jul 7, 2026 | Farrell Michael J. | Chairman and CEO | Other | 4,991 | 146.34 | 730,383 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.